Pelican Cancer Foundation

Pelican Cancer Foundation

  • Facebook
  • Instagram
  • Twitter
  • YouTube
DONATE NOW
  • Home
  • About Us
    • What we do
      • Bowel cancer
      • Colorectal Liver Metastases
      • Prostate cancer
      • Bladder cancer
      • Pseudomyxoma peritonei
      • Our Research
      • Our achievements
      • Media
    • Who we are
      • Our board
      • Our team
      • Pelican Patrons
    • Our annual accounts
    • Pelican Cancer Foundation – What next?
    • Support Us
    • Job opportunities
    • Partners
  • Workshops
    • TIPTOP
      • Workshops
      • TIPTOP – Online resources
    • Pelican IMPACT
      • IMPACT – Completion & Evaluation
      • Workshops
      • IMPACT – Online resources
      • IMPACT – Partners and Sponsors
    • SPECC
      • SPECC – Completion & Evaluation
      • Workshops
      • SPECC – Online resources
      • SPECC – Partners and Sponsors
    • LOREC
    • What clinicians say about our courses
    • Faculty
    • Our sponsors
    • Become a sponsor
    • Request a course or topic
    • Give us feedback
    • Previous courses
  • Videos
  • Research
    • Research strategy
    • Bowel cancer research
      • POLARS
      • MERCURY 2 (Low Rectal Cancer Study)
      • Deferral of surgery study
      • TATME
      • IMPRESS
      • TRIGGER
      • Papers of interest
      • Timing of surgery
      • AMSOEC
      • MINSTREL
      • Completed research
        • Perineal wound healing registry
        • Beyond TME
        • Validation of the LARS score
        • MARVEL: Evaluation of EMVI positive rectal cancer
        • FLEX
        • TME Physical Simulation Model
        • Total Mesorectal Excision (TME)
        • MERCURY research programme
    • Peritoneal malignancy research
      • Colorectal Peritoneal Malignancy Database
      • Pseudomyxoma Pathology Atlas
    • Prostate Cancer Research
      • Focal therapy and HIFU research
      • MRI research for prostate cancer
      • Prostate cancer colloquiums
      • FORECAST
      • Trachtomap
      • Papers of interest
    • Liver cancer research
      • Completed research
        • EORTC studies
      • SERENADE
      • Papers of interest
    • Bladder cancer research
      • Papers of interest
    • Peer reviewers
    • Clinical trials
    • Information for researchers
      • Peer review process
      • Research review panel
      • Research Grant Application Guidance Notes
      • Terms and conditions of grants
      • Animals in medical research
      • Research costs
    • Surgical videos
  • For Patients
    • Patient stories
      • Bob’s story (prostate cancer)
      • Andrew’s story (prostate cancer)
      • Alan’s story (prostate cancer)
      • Raymond’s story (prostate cancer)
      • Anthony’s story (bowel cancer)
      • Elena’s story (bowel cancer)
      • Jay’s story (bladder cancer)
      • Terry’s story (liver cancer)
      • Derrick’s story (liver cancer)
      • Alex’s story (colorectal cancer)
      • Cheryll’s story (rectal cancer)
      • Eileen’s story
      • Richard’s story – irrigation
      • Tom’s story – complete response
      • Advanced metastatic bowel cancer
    • Bowel cancer
      • Our bowel cancer team
      • About bowel cancer treatment – TME
      • April – Bowel Cancer Awareness Month
      • Low rectal cancer
      • Complete response to chemoradiotherapy in rectal cancer
      • Frequently asked questions about bowel cancer
      • Irrigation for colostomies
      • A patient’s advice
      • Symptom checker
      • Bowel cancer – useful contacts
    • Liver cancer
      • Our liver cancer team
      • About liver cancer treatment
      • Interventional radiology
      • Liver cancer – frequently asked questions
      • Carcinoid and neuroendocrine tumours
      • Liver cancer – want to read more?
    • Prostate cancer
      • Our prostate cancer team
      • Prostate cancer treatment options
      • Pelican’s position
    • Bladder cancer
      • Blue light cystoscopy
      • Bladder cancer – useful contacts
    • Pseudomyxoma peritonei
    • Kidney cancer
      • Our kidney cancer team
      • Kidney cancer – useful contacts
    • What is an MDT?
      • What an MRI reveals
      • Reporting cancer outcomes
    • Getting a second opinion
    • Clinical trials
      • Current clinical trials
    • Tell us your story
    • Still got questions about cancer?
    • Links
  • Support us
    • Make a donation
      • Make a donation
      • Why donate to Pelican?
      • Donate shares
      • Donate in memory
      • How your donations are spent
    • Fundraising
      • Our fundraisers
      • Fundraising ideas
      • Fundraising challenges
      • Fundraising resources
      • Our events
    • Leaving a Legacy
    • Volunteering Opportunities
    • Could you host a Pelican Talk?
    • Charity of the Year partnerships
    • Pelican Film Society
  • Shop
  • Events
  • Contact us

MRI research for prostate cancer

Over the last 20 years, the use of Magnetic Resonance Imaging (MRI) has dramatically increased in all areas of medicine. MRI is a unique imaging modality providing a non-invasive method of acquiring clinical imaging information without exposing patients to potentially harmful ionizing radiation.

For prostate cancer, MRI is traditionally used AFTER biopsy. The theory being that a transanal ultrasound (TRUS) is used to guide the biopsy to the gland and then the histopathology will demonstrate if any tumour is present. However, the biopsy often makes images inside the gland unreadable. This is because the biopsy needles damage the tissues of the prostate gland and create ‘artefact’, meaning that MRI cannot read any information within the gland.

Pelican is interested in research that investigates the use of MRI BEFORE biopsy that can image the gland for significant, clinically-important cancer. There is an increasing belief amongst a number of clinicians that this is possible, but further research is necessary to find a modality that can provide sufficient clarity and information.

Pelican has previous experience of the importance of MRI, and also the challenges of finding an effective modality and convincing clinicians of its value. Professor Gina Brown has developed a method of using MRI to assist in clinical decision-making for bowel cancer treatment. Fifteen years ago there was extensive cynicism about the use of MRI for bowel cancer – it is now mandatory for all bowel cancer patients.

At present, the role of imaging is to determine the stage of the prostate cancer, specifically whether or not the disease extends beyond the prostate gland. There is no established imaging technique that provides information about the likely biological behaviour of the disease.

Dr Clare Allen and Dr Alex Kirkham at University College London Hospital (UCLH) have successfully developed protocols to identify malignant tumours within the prostate gland using MRI. They use different modalities of MRI to produce the best anatomical data. The aim of the research is to evaluate if any MRI can be of use in predicting the future biological behaviour of the early prostate cancer.

MRI scans also allow the whole of the prostate to be examined. Previously, urologists believed that there were few tumours in the ‘front’ (anterior) of the prostate gland. This was because a 12 needle biopsy cannot reach this area. MRI and prostate mapping biopsies allow a thorough investigation of the whole prostate and precise treatment.

In addition to supporting research in this area – Pelican Cancer Foundation has also organised a series of Prostate Cancer Colloquiums where leading medical professionals can meet and discuss recent research into the various imaging techniques and their consequences for prostate cancer treatment.

Pelican Cancer FoundationFollow

Driving innovation and advancing surgery to help patients live well, for longer.

Pelican Cancer Foundation
ChrisGBoultonChris Boulton@ChrisGBoulton·
12 May

Today's taster of my Big Mountains Exhibition at the @westridgestudio Highclere on 21/22 May is my triptych of the Monte Rosa Massif. #oswbnh2022 #westridgestudio #artexibition #openstudios #bigmountains #alpsmountains #monterosa #pelicancancerfoundation #mycancermychoices

Reply on Twitter 1524787378711404545Retweet on Twitter 15247873787114045451Like on Twitter 15247873787114045451Twitter 1524787378711404545
Pelican_CancerPelican Cancer Foundation@Pelican_Cancer·
10 May

👇 Available to watch now - http://pelicancancervideos.org
🎥Lapco - training laparoscopic colorectal surgeons

@TomCecilMD @lapcoleadmark @Brendan92855812 @ProfessorHeald

Reply on Twitter 1523904919253786625Retweet on Twitter 15239049192537866256Like on Twitter 15239049192537866258Twitter 1523904919253786625
Pelican_CancerPelican Cancer Foundation@Pelican_Cancer·
9 May

👇 Available to tomorrow 10/05/2022 - @TomCecilMD @lapcoleadmark @Brendan92855812
@ProfessorHeald discuss 'Lapaco - training laparoscopic colorectal surgeons'

Reply on Twitter 1523682093058129920Retweet on Twitter 15236820930581299202Like on Twitter 15236820930581299203Twitter 1523682093058129920
Load More...

To view our privacy policy - click here.
Registered charity no: 1141911

Copyright © 2022 · Outreach Pro Theme on Genesis Framework · WordPress · Log in